New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 11, 2012
05:55 EDTTHOR, THOR, HTWR, HTWRLeerink's medical devices analyst hosts a meeting
Medical Supplies & Devices Analyst Antalffy, along with Director of the Mechanical Circulatory Support & Heart Failure Device Program at the University of California, Dr. Klein, and Director of the Heart Failure Program at Stanford University Medical Center, Dr. Fowler, hold a discussion entitled, "Debating the Future of LVADs: Long-Term Market Growth Prospects and THOR vs. HTWR" in Palo Alto, California on December 12.
News For THOR;HTWR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 31, 2014
07:51 EDTHTWRHeartWare price target lowered to $115 from $125 at Canaccord
Subscribe for More Information
October 30, 2014
07:00 EDTHTWRHeartWare reports Q3 EPS (64c), consensus (65c)
Subscribe for More Information
October 28, 2014
10:12 EDTTHOROn The Fly: Analyst Downgrade Summary
Subscribe for More Information
05:40 EDTTHORThoratec downgraded to Equal Weight from Overweight at Barclays
Subscribe for More Information
October 21, 2014
15:00 EDTHTWRUpdate suggests HeartWare CE mark trial on track, says Wells Fargo
Wells Fargo said the posting for HeartWare's MVAD CE Mark trial, which had not been changed since April 2013, was updated on October 16 and now indicates the trial is scheduled to start in April 2015. Wells expects HeartWare to update on MVAD on its Q3 call next week, but the firm said that it does not expect any major surprises based on the updated posting. Wells Fargo maintains its Market Perform rating on HeartWare.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use